These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 19082464)
41. Fibroblast growth factor 1 and fibroblast growth factor 2 immunoreactivity in gastrointestinal tumours. el-Hariry I; Pignatelli M; Lemoine N J Pathol; 1997 Jan; 181(1):39-45. PubMed ID: 9072001 [TBL] [Abstract][Full Text] [Related]
42. FANCD2 mRNA overexpression is a bona fide indicator of lymph node metastasis in human colorectal cancer. Ozawa H; Iwatsuki M; Mimori K; Sato T; Johansson F; Toh H; Watanabe M; Mori M Ann Surg Oncol; 2010 Sep; 17(9):2341-8. PubMed ID: 20339950 [TBL] [Abstract][Full Text] [Related]
43. Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma. Ueki T; Koji T; Tamiya S; Nakane PK; Tsuneyoshi M J Pathol; 1995 Dec; 177(4):353-61. PubMed ID: 8568589 [TBL] [Abstract][Full Text] [Related]
44. Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers. Fujimoto J; Hori M; Ichigo S; Tamaya T Invasion Metastasis; 1995; 15(5-6):203-10. PubMed ID: 8765195 [TBL] [Abstract][Full Text] [Related]
45. Fibroblast growth factor-2 expression during experimental oral carcinogenesis. Its possible role in the induction of pre-malignant fibrosis. Raimondi AR; Molinolo AA; Itoiz ME J Oral Pathol Med; 2006 Apr; 35(4):212-7. PubMed ID: 16519768 [TBL] [Abstract][Full Text] [Related]
46. Clinical significance of STC1 gene expression in patients with colorectal cancer. Tamura S; Oshima T; Yoshihara K; Kanazawa A; Yamada T; Inagaki D; Sato T; Yamamoto N; Shiozawa M; Morinaga S; Akaike M; Kunisaki C; Tanaka K; Masuda M; Imada T Anticancer Res; 2011 Jan; 31(1):325-9. PubMed ID: 21273618 [TBL] [Abstract][Full Text] [Related]
47. Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. Gessi S; Cattabriga E; Avitabile A; Gafa' R; Lanza G; Cavazzini L; Bianchi N; Gambari R; Feo C; Liboni A; Gullini S; Leung E; Mac-Lennan S; Borea PA Clin Cancer Res; 2004 Sep; 10(17):5895-901. PubMed ID: 15355922 [TBL] [Abstract][Full Text] [Related]
48. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro. Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972 [TBL] [Abstract][Full Text] [Related]
49. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex. Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443 [TBL] [Abstract][Full Text] [Related]
50. Expression of basic fibroblast growth factor and its receptors in human ovarian follicles from adults and fetuses. Ben-Haroush A; Abir R; Ao A; Jin S; Kessler-Icekson G; Feldberg D; Fisch B Fertil Steril; 2005 Oct; 84 Suppl 2():1257-68. PubMed ID: 16210019 [TBL] [Abstract][Full Text] [Related]
51. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783 [TBL] [Abstract][Full Text] [Related]
52. Relationship between RegIV gene expression to outcomes in colorectal cancer. Numata M; Oshima T; Yoshihara K; Watanabe T; Tsuchida K; Tamagawa H; Yamamoto N; Shiozawa M; Morinaga S; Akaike M; Kunisaki C; Rino Y; Tanaka K; Masuda M; Imada T J Surg Oncol; 2011 Aug; 104(2):205-9. PubMed ID: 21381041 [TBL] [Abstract][Full Text] [Related]
53. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer]. Zhang FR; He XB; Yang YH; Xie W Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496 [TBL] [Abstract][Full Text] [Related]
54. Costimulation of human CD4+ T cells by fibroblast growth factor-1 (acidic fibroblast growth factor). Zhao XM; Byrd VM; McKeehan WL; Reich MB; Miller GG; Thomas JW J Immunol; 1995 Oct; 155(8):3904-11. PubMed ID: 7561097 [TBL] [Abstract][Full Text] [Related]
55. [Expression of osteopontin mRNA and its protein in colorectal cancer and liver metastatic tissues]. Ding L; Zheng S; Cao J Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(14):970-3. PubMed ID: 12181091 [TBL] [Abstract][Full Text] [Related]
56. Human fibroblast growth factor receptor 1-IIIb is a functional fibroblast growth factor receptor expressed in the pancreas and involved in proliferation and movement of pancreatic ductal cells. Liu Z; Ishiwata T; Zhou S; Maier S; Henne-Bruns D; Korc M; Bachem M; Kornmann M Pancreas; 2007 Aug; 35(2):147-57. PubMed ID: 17632321 [TBL] [Abstract][Full Text] [Related]
57. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium. Soufla G; Sifakis S; Spandidos DA Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148 [TBL] [Abstract][Full Text] [Related]
58. The significance of PITX2 overexpression in human colorectal cancer. Hirose H; Ishii H; Mimori K; Tanaka F; Takemasa I; Mizushima T; Ikeda M; Yamamoto H; Sekimoto M; Doki Y; Mori M Ann Surg Oncol; 2011 Oct; 18(10):3005-12. PubMed ID: 21479692 [TBL] [Abstract][Full Text] [Related]
59. Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis. Huang X; Yu C; Jin C; Yang C; Xie R; Cao D; Wang F; McKeehan WL Mol Carcinog; 2006 Dec; 45(12):934-42. PubMed ID: 16929488 [TBL] [Abstract][Full Text] [Related]
60. Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer. Noike T; Miwa S; Soeda J; Kobayashi A; Miyagawa S Hum Pathol; 2008 Feb; 39(2):201-8. PubMed ID: 17949784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]